David Gorski

Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy.

Dual induction of the Epo-Egr-TNF-alpha- plasmid in hypoxic human colon adenocarcinoma produces tumor growth delay.

Inhibition of endothelial cell activation by the homeobox gene Gax.

Control of vascular cell differentiation by homeobox transcription factors.

Differential expression of vascular endothelial growth factor-A isoforms at different stages of melanoma progression.

Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma.

The homeobox gene Gax inhibits angiogenesis through inhibition of nuclear factor-kappaB-dependent endothelial cell gene expression.

Detection of B-RAF and N-RAS mutations in human melanoma.

The homeobox gene GAX activates p21WAF1/CIP1 expression in vascular endothelial cells through direct interaction with upstream AT-rich sequences.

Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5.

MEOX2 regulates nuclear factor-kappaB activity in vascular endothelial cells through interactions with p65 and IkappaBbeta.

Regulation of the expression and activity of the antiangiogenic homeobox gene GAX/MEOX2 by ZEB2 and microRNA-221.

Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer.

Complementary medicine for fatigue and cortisol variability in breast cancer survivors.

Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ.

Common breast symptoms: when to refer to a breast surgeon.

Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.

Metabotropic glutamate receptor-1 as a novel target for the antiangiogenic treatment of breast cancer.

Clinical trials of integrative medicine: testing whether magic works?

Integrative oncology: really the best of both worlds?

Considering prior plausibility in clinical trials does not mean ignoring scientific evidence.

PDGFRα and β play critical roles in mediating Foxq1-driven breast cancer stemness and chemoresistance.

Integrative oncology - strong science is needed for better patient care.

The role of academic health centres to inform evidence-based integrative oncology practice.

Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.

Trends in Metastatic Breast and Prostate Cancer.

Riluzole mediates anti-tumor properties in breast cancer cells independent of metabotropic glutamate receptor-1.

HER2 status and disparities in luminal breast cancers.